The average cost of a healthcare data breach is now $10.93 million, up from $10.10 million in 2022, according to a new report. Healthcare has the highest data breach costs of all industries — breaches are second costliest in the financial sector, where the average cost is $5.9 million.
The healthcare provider and technology giant have entered into a 10-year partnership that will leverage AI, cloud and quantum computing capabilities to accelerate research. The collaboration will include the first private-sector installation of the IBM Quantum System One.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
IBM is reportedly looking to sell its Watson Health business. If true, it would be another stumble in a much-hyped healthcare project by a technology company.
While the lead author of the study, at the Oak Ridge National Laboratory, cautioned that the researchers had not found a cure for the virus that causes COVID-19, they were able to identify 77 compounds after screening more than 8,000 in a matter of days.
The DOJ claims that IBM subsidiary Cúram Software misrepresented its ability to meet specified technical requirements in its contract to develop Maryland's health insurance exchange website and IT platform.
The program is open to early-stage health tech and fintech startups that are pre-Series A, less than five years old and have less than $1 million in revenue. The application deadline is 5 PM PT on July 31, 2019.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
The four companies are collaborating under a program that stems from a law that Congress passed in 2013 to develop an electronic pharmaceutical tracking system.
Last month, it was reported that IBM would stop selling Watson for Drug Discovery, but executives in the field of biopharma artificial intelligence say the field is still going strong.
IBM is stopping the development and sales of the product, which uses Watson AI to help pharmaceutical companies find new drugs, because it wasn't yielding large enough financial returns, according to a STAT report.
CTA's working group, which includes more than 30 different organizations, is an effort to bring stakeholders together to create common understanding around AI definitions, proper data management and ethical considerations like bias and privacy.
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
These two announcements come after Deborah DiSanzo left her role as IBM Watson Health general manager last year.
At the ongoing HIMSS conference in Orlando, Florida, the companies' Canadian divisions said their partnership would mark the technology's first use in clinical trials in Canada.
Even as the hype around cryptocurrencies like Bitcoin have died down, major players are investing in applications to bring blockchain to healthcare.
The program from IBM Israel and Hadassah Medical Center, which will begin in the first quarter of 2019 and last six months, is open to startups that have completed a post-seed round of financing, according to Israeli publication Globes.
In a phone interview, Jamie Thomas, general manager of strategy and development for IBM Systems, advised healthcare IT executives to have a data management strategy and to keep security top of mind.